Manish A. Shah, MD, discusses 5-year outcomes from the KEYNOTE-590 trial of frontline pembrolizumab plus chemotherapy in patients with esophageal cancer.
E-Mail
IMAGE: In the dental plaque samples, the prevalence of all bacteria, with the exception of F. nucleatum, was significantly higher in the test group versus the control group. The pie charts. view more
Credit: Department of Periodontology,TMDU
Researchers led by Tokyo Medical and Dental University (TMDU) find that certain oral pathogens are more prevalent in esophageal cancer patients, and could be used as a novel diagnostic tool
Tokyo, Japan - It is increasingly clear that the trillions of bacteria that make themselves at home in and on the human body are more than just casual observers along for the ride. Gut bacteria in particular have been shown to have an enormous influence on human health, with studies suggesting they play a role in illnesses ranging from autoimmune disorders to anxiety and depression.